CORT |
Corcept Therapeutics Incorporated |
0 |
5.47% |
|
|
|
|
|
N/A |
0.00% |
65.42% |
36.69% |
---|
BMY |
Bristol-Myers Squibb Company |
0 |
4.38% |
|
|
|
|
|
N/A |
0.00% |
31.00% |
27.64% |
---|
ITCI |
INTRA CELLULAR THERAPIES INC |
|
4.32% |
|
|
|
|
|
|
|
|
|
---|
JAZZ |
Jazz Pharmaceuticals plc |
0 |
4.22% |
|
|
|
|
|
N/A |
0.00% |
31.17% |
52.18% |
---|
VTRS |
Viatris Inc. |
0 |
4.04% |
|
|
|
|
|
N/A |
0.00% |
30.87% |
29.47% |
---|
CTLT |
CATALENT INC |
|
4.00% |
|
|
|
|
|
|
|
|
|
---|
AXSM |
Axsome Therapeutics, Inc. |
0 |
3.72% |
|
|
|
|
|
N/A |
0.00% |
49.12% |
5.12% |
---|
PRGO |
Perrigo Company plc |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
43.05% |
20.57% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
3.48% |
|
|
|
|
|
N/A |
0.00% |
72.63% |
20.17% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
0 |
3.46% |
|
|
|
|
|
N/A |
0.00% |
89.13% |
16.05% |
---|
RPRX |
Royalty Pharma plc |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
31.94% |
29.60% |
---|
PFE |
Pfizer Inc. |
0 |
3.38% |
|
|
|
|
|
N/A |
0.00% |
26.97% |
13.94% |
---|
ZTS |
Zoetis Inc. |
0 |
3.34% |
|
|
|
|
|
N/A |
0.00% |
29.70% |
24.44% |
---|
JNJ |
Johnson & Johnson |
0 |
3.31% |
|
|
|
|
|
N/A |
0.00% |
19.10% |
20.87% |
---|
MRK |
Merck & Co., Inc. |
0 |
3.24% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
---|
ELAN |
Elanco Animal Health Incorporated |
0 |
3.20% |
|
|
|
|
|
N/A |
0.00% |
53.28% |
18.79% |
---|
LLY |
Eli Lilly and Company |
0 |
3.18% |
|
|
|
|
|
N/A |
0.00% |
40.95% |
42.16% |
---|
OGN |
Organon & Co. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
45.12% |
74.83% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
0 |
2.65% |
|
|
|
|
|
N/A |
0.00% |
28.23% |
22.40% |
---|
PCRX |
Pacira BioSciences, Inc. |
0 |
2.53% |
|
|
|
|
|
N/A |
0.00% |
55.77% |
15.04% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
0 |
2.36% |
|
|
|
|
|
N/A |
0.00% |
43.71% |
27.41% |
---|
ARVN |
Arvinas, Inc. |
0 |
2.11% |
|
|
|
|
|
N/A |
0.00% |
150.95% |
32.38% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
0 |
2.01% |
|
|
|
|
|
N/A |
0.00% |
51.23% |
29.31% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
0 |
1.99% |
|
|
|
|
|
N/A |
0.00% |
55.34% |
84.59% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
0 |
1.66% |
|
|
|
|
|
N/A |
0.00% |
55.89% |
16.76% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
0 |
1.59% |
|
|
|
|
|
N/A |
0.00% |
50.20% |
37.95% |
---|
OCUL |
Ocular Therapeutix, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
132.65% |
59.45% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
0 |
1.35% |
|
|
|
|
|
N/A |
0.00% |
54.28% |
20.68% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
1.32% |
|
|
|
|
|
N/A |
0.00% |
67.35% |
47.41% |
---|
FULC |
Fulcrum Therapeutics, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
141.59% |
26.85% |
---|
WVE |
Wave Life Sciences Ltd. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
317.00% |
44.24% |
---|
MNMD |
Mind Medicine (MindMed) Inc. |
0 |
1.18% |
|
|
|
|
|
N/A |
0.00% |
97.75% |
24.00% |
---|
LQDA |
Liquidia Corporation |
0 |
1.09% |
|
|
|
|
|
N/A |
0.00% |
66.08% |
40.08% |
---|
PLRX |
Pliant Therapeutics, Inc. |
0 |
1.06% |
|
|
|
|
|
N/A |
0.00% |
117.25% |
9.21% |
---|
HROW |
Harrow Health, Inc. |
0 |
1.03% |
|
|
|
|
|
N/A |
0.00% |
89.52% |
12.09% |
---|
INVA |
Innoviva, Inc. |
0 |
1.02% |
|
|
|
|
|
N/A |
0.00% |
52.77% |
25.74% |
---|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
0 |
0.82% |
|
|
|
|
|
N/A |
0.00% |
105.51% |
65.99% |
---|
EYPT |
EyePoint Pharmaceuticals, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
103.49% |
14.57% |
---|
ELVN |
Enliven Therapeutics, Inc. |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
78.13% |
45.81% |
---|
NUVB |
Nuvation Bio Inc. |
0 |
0.64% |
|
|
|
|
|
N/A |
0.00% |
256.22% |
70.07% |
---|
EOLS |
Evolus, Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
71.45% |
77.07% |
---|
XERS |
Xeris Biopharma Holdings, Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
186.20% |
73.76% |
---|
PHAT |
Phathom Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
143.88% |
69.53% |
---|
SAVA |
Cassava Sciences, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
122.51% |
8.07% |
---|
|
SSI US GOV MONEY MARKET CLASS |
|
N/A |
|
|
|
|
|
|
|
|
|
---|